Cleared Traditional

K132777 - NANOCROSS ELITE .14 OVER-THE-WIRE PTA, BALLOON DILATION CATHETER

K132777 is an FDA 510(k) clearance for NANOCROSS ELITE .14 OVER-THE-WIRE PTA, manufactured by Ev3, Inc.. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 21-day FDA review.

K132777 · Ev3, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2013
Decision
21d
Days
Class 2
Risk

K132777 is an FDA 510(k) clearance for the NANOCROSS ELITE .14 OVER-THE-WIRE PTA, BALLOON DILATION CATHETER. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Ev3, Inc. (Plymouth, US). The FDA issued a Cleared decision on September 26, 2013 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ev3, Inc. devices

FDA 510(k) Submission Details - K132777

510(k) Number K132777 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 05, 2013
Decision Date September 26, 2013
Days to Decision 21 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 125d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 345
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K132777.
PROTEUS PTA BALLOON CATHETER WITH EMBOLIC CAPTURE FEATURE
K133043 · Angioslide, Ltd. · Dec 2013
ADVANCE 34LP LOW PROFILE PTA BALLOON DILATATION CATHETER
K132020 · Cook, Inc. · Oct 2013
STERLING OVER-THE-WIRE (OTW) PTA BALLOON DILATATION CATHETER
K132430 · Boston Scientific Corp · Oct 2013
ARROW GPSCATH BALLOON DILATATION CATHETER
K130397 · Hotspur Technologies · Jun 2013
CHOCOLATE PTA BALLOON CATHETER (OVER THE WIRE) 0.014 GUIDE WIRE, CHOCOLATE PTA BALLOON CATHETER (OVER THE WIRE) 0.018
K130414 · Trireme Medical, Inc. · Jun 2013
VECTOR PTA BALLOON DILATATION CATHETER
K131329 · R4 Vascular, Inc. · Jun 2013